Evidence map›Paper›PMID 20522802›Full record

ArticleCirculation research2010

Cardiomyogenesis in the adult human heart.

Jan Kajstura, Konrad Urbanek, Shira Perl, Toru Hosoda, Hanqiao Zheng, Barbara Ogórek, João Ferreira-Martins, Polina Goichberg, Carlos Rondon-Clavo, Fumihiro Sanada and 7 more

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Circulation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 308 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Role of PI3K/Akt signaling pathway in cardiac fibrosis.Molecular and cellular biochemistry · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Long Non-coding RNA ECRAR Triggers Post-natal Myocardial Regeneration by Activating ERK1/2 Signaling.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Jan KajsturaDepartment of Anesthesia and Medicine, and Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA. jkajstura@partners.org
Konrad Urbanek
Shira Perl
Toru Hosoda
Hanqiao Zheng
Barbara Ogórek
João Ferreira-Martins
Polina Goichberg
Carlos Rondon-Clavo
Fumihiro Sanada
Domenico D'Amario
Marcello Rota
Federica Del Monte
Donald Orlic
John Tisdale
Annarosa Leri
Piero Anversa
National Heart Lung and Blood Institute · USNational Institutes of Health · US

Funding

Tumor Necrosis Factor Modulation of CPCsP01HL078825 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2005 to 2021
$37.6M
Isolation, characterization, and transplantation of candidate stem cellsZIAHL006009 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI TISDALE, JOHN · 2009 to 2025
$13.5M
Rebuilding the Failing HeartP01HL092868 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ANVERSA, PIERO · 2008 to 2013
$12.9M
Stem Cells and Cardiac AgingP01AG023071 · NIA · NEW YORK MEDICAL COLLEGE · PI ANVERSA, PIERO · 2004 to 2008
$9.5M
Repair and Angiogenesis by Stem Cells in Human HeartR37HL081737 · NHLBI · NEW YORK MEDICAL COLLEGE · PI ANVERSA, PIERO · 2005 to 2015
$6.5M
IGF-1, Gender, Heart Failure and Longevity: A Paradigm ShiftR01AG017042 · NIA · NEW YORK MEDICAL COLLEGE · PI ANVERSA, PIERO · 2000 to 2010
$5.3M
Coronary Vasculature Progenitor Cell in Human Ischemic Heart FailureR01HL039902 · NHLBI · NEW YORK UNIVERSITY · PI ANVERSA, PIERO, KAJSTURA, JAN · 1989 to 2012
$4.7M
Stem Cells in the Developing HeartR01HL091021 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROTA, MARCELLO · 2009 to 2013
$2.4M
Redefining Human Myocardial BiologyR01HL105532 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ANVERSA, PIERO, BUCHHOLZ, BRUCE A · 2011 to 2014
$2.2M
IGF-1 and Diabetic HeartR01HL065573 · NHLBI · NEW YORK MEDICAL COLLEGE · PI KAJSTURA, JAN · 2001 to 2010
$2.1M
Immortal DNA Strand and Cardiac Stem Cell AgingR01AG037495 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI ANVERSA, PIERO · 2011 to 2014
$2.0M
Cardiac Stem Cell Growth, Aging and DeathR01HL075480 · NHLBI · NEW YORK MEDICAL COLLEGE · PI KAJSTURA, JAN · 2004 to 2008
$1.9M
NHLBI NIH HHS P01 HL078825NHLBI NIH HHS P01 HL092868NHLBI NIH HHS R01 HL039902NHLBI NIH HHS R01 HL065573NHLBI NIH HHS R01 HL075480NHLBI NIH HHS R01 HL091021NHLBI NIH HHS R01 HL111183NHLBI NIH HHS R37 HL081737NIA NIH HHS P01 AG023071NIA NIH HHS R01 AG017042NIA NIH HHS R01 AG037495
6 · The paper itself

Abstract

rationaleThe ability of the human heart to regenerate large quantities of myocytes remains controversial, and the extent of myocyte renewal claimed by different laboratories varies from none to nearly 20% per year.

objectiveTo address this issue, we examined the percentage of myocytes, endothelial cells, and fibroblasts labeled by iododeoxyuridine in postmortem samples obtained from cancer patients who received the thymidine analog for therapeutic purposes. Additionally, the potential contribution of DNA repair, polyploidy, and cell fusion to the measurement of myocyte regeneration was determined. METHODS AND

resultsThe fraction of myocytes labeled by iododeoxyuridine ranged from 2.5% to 46%, and similar values were found in fibroblasts and endothelial cells. An average 22%, 20%, and 13% new myocytes, fibroblasts, and endothelial cells were generated per year, suggesting that the lifespan of these cells was approximately 4.5, 5, and 8 years, respectively. The newly formed cardiac cells showed a fully differentiated adult phenotype and did not express the senescence-associated protein p16(INK4a). Moreover, measurements by confocal microscopy and flow cytometry documented that the human heart is composed predominantly of myocytes with 2n diploid DNA content and that tetraploid and octaploid nuclei constitute only a small fraction of the parenchymal cell pool. Importantly, DNA repair, ploidy formation, and cell fusion were not implicated in the assessment of myocyte regeneration.

conclusionsOur findings indicate that the human heart has a significant growth reserve and replaces its myocyte and nonmyocyte compartment several times during the course of life.

Indexed as

Cell ProliferationMuscle DevelopmentAdultAgedAge FactorsAnimalsAutopsyCell DeathCell FusionCell NucleusDNA RepairEndothelial CellsFemaleFibroblastsFlow CytometryHumansIdoxuridineRadiation-Sensitizing Agents

Identifiers

PMID20522802
PMCPMC2987602
OpenAlexW2037424183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.